|
1
|
Vargas R, Repke JT and Ural SH: Type 1
diabetes mellitus and pregnancy. Rev Obstet Gynecol. 3:92–100.
2010.PubMed/NCBI
|
|
2
|
Achenbach P, Bonifacio E and Ziegler AG:
Predicting type 1 diabetes. Curr Diab Rep. 5:98–103. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herold KC, Vignali DA, Cooke A and
Bluestone JA: Type 1 diabetes: Translating mechanistic observations
into effective clinical outcomes. Nat Rev Immunol. 13:243–256.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bluestone JA, Herold K and Eisenbarth G:
Genetics, pathogenesis and clinical interventions in type 1
diabetes. Nature. 464:1293–1300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang L and Eisenbarth GS: Prediction and
prevention of Type 1 diabetes mellitus. J Diabet. 3:48–57. 2011.
View Article : Google Scholar
|
|
6
|
Wu H, Kong L, Zhou S, Cui W, Xu F, Luo M,
Li X, Tan Y and Miao L: The role of microRNAs in diabetic
nephropathy. J Diabetes Res. 2014:9201342014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Z, Chen H, Si H, Li X, Ding X, Sheng
Q, Chen P and Zhang H: Serum miR-23a, a potential biomarker for
diagnosis of pre-diabetes and type 2 diabetes. Acta Diabetol.
51:823–831. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karolina DS, Armugam A, Tavintharan S,
Wong MT, Lim SC, Sum CF and Jeyaseelan K: MicroRNA 144 impairs
insulin signaling by inhibiting the expression of insulin receptor
substrate 1 in type 2 diabetes mellitus. PLoS One. 6:e228392011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung AC, Huang XR, Meng X and Lan HY:
miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc
Nephrol. 21:1317–1325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kato M, Arce L and Natarajan R: MicroRNAs
and their role in progressive kidney diseases. Clin J Am Soc
Nephrol. 4:1255–1266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krupa A, Jenkins R, Luo DD, Lewis A,
Phillips A and Fraser D: Loss of MicroRNA-192 promotes fibrogenesis
in diabetic nephropathy. J Am Soc Nephrol. 21:438–447. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Párrizas M, Brugnara L, Esteban Y,
González-Franquesa A, Canivell S, Murillo S, Gordillo-Bastidas E,
Cussó R, Cadefau JA, García-Roves PM, et al: Circulating miR-192
and miR-193b are markers of prediabetes and are modulated by an
exercise intervention. J Clin Endocrinol Metab. 100:E407–E415.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asgeirsdóttir SA, van Solingen C, Kurniati
NF, Zwiers PJ, Heeringa P, van Meurs M, Satchell SC, Saleem MA,
Mathieson PW, Banas B, et al: MicroRNA-126 contributes to renal
microvascular heterogeneity of VCAM-1 protein expression in acute
inflammation. Am J Physiol Renal Physiol. 302:F1630–F1639. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Drucker DJ: Glucagon-like peptides.
Diabetes. 47:159–169. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Drucker DJ, Philippe J, Mojsov S, Chick WL
and Habener JF: Glucagon-like peptide I stimulates insulin gene
expression and increases cyclic AMP levels in a rat islet cell
line. Proc Natl Acad Sci USA. 84:3434–3438. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Turton MD, O'Shea D, Gunn I, Beak SA,
Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, et
al: A role for glucagon-like peptide-1 in the central regulation of
feeding. Nature. 379:69–72. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Flint A, Raben A, Astrup A and Holst JJ:
Glucagon-like peptide 1 promotes satiety and suppresses energy
intake in humans. J Clin Invest. 101:515–520. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abello J, Ye F, Bosshard A, Bernard C,
Cuber JC and Chayvialle JA: Stimulation of glucagon-like peptide-1
secretion by muscarinic agonist in a murine intestinal endocrine
cell line. Endocrinology. 134:2011–2017. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brubaker PL and Vranic M: Fetal rat
intestinal cells in monolayer culture: A new in vitro system to
study the glucagon-like immunoreactive peptides. Endocrinology.
120:1976–1985. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buchan AM, Barber DL, Gregor M and Soll
AH: Morphologic and physiologic studies of canine ileal
enteroglucagon-containing cells in short-term culture.
Gastroenterology. 93:791–800. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brubaker PL, Schloos J and Drucker DJ:
Regulation of glucagon-like peptide-1 synthesis and secretion in
the GLUTag enteroendocrine cell line. Endocrinology. 139:4108–4114.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Remor AP, de Matos FJ, Ghisoni K, da Silva
TL, Eidt G, Búrigo M, de Bem AF, Silveira PC, de León A, Sanchez
MC, et al: Differential effects of insulin on peripheral
diabetes-related changes in mitochondrial bioenergetics:
Involvement of advanced glycosylated end products. Biochim Biophys
Acta. 1812:1460–1471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
American Diabetes Association, : Diagnosis
and classification of diabetes mellitus. Diabetes Care. 35 Suppl
1:S64–S71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lo SH, Cheng KC, Li YX, Chang CH, Cheng JT
and Lee KS: Development of betulinic acid as an agonist of TGR5
receptor using a new in vitro assay. Drug Des Devel Ther.
10:2669–2676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cordier-Bussat M, Bernard C, Levenez F,
Klages N, Laser-Ritz B, Philippe J, Chayvialle JA and Cuber JC:
Peptones stimulate both the secretion of the incretin hormone
glucagon-like peptide 1 and the transcription of the proglucagon
gene. Diabetes. 47:1038–1045. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reimer RA, Darimont C, Gremlich S,
Nicolas-Métral V, Rüegg UT and Macé K: A human cellular model for
studying the regulation of glucagon-like peptide-1 secretion.
Endocrinology. 142:4522–4528. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park JG, Oie HK, Sugarbaker PH, Henslee
JG, Chen TR, Johnson BE and Gazdar A: Characteristics of cell lines
established from human colorectal carcinoma. Cancer Res.
47:6710–6718. 1987.PubMed/NCBI
|
|
31
|
de Bruïne AP, Dinjens WN, van der Linden
EP, Pijls MM, Moerkerk PT and Bosman FT: Extracellular matrix
components induce endocrine differentiation in vitro in NCI-H716
cells. The Am J Pathol. 142:773–782. 1993.PubMed/NCBI
|
|
32
|
de Bruïne AP, Dinjens WN, Pijls MM, vd
Linden EP, Rousch MJ, Moerkerk PT, de Goeij AF and Bosman FT:
NCI-H716 cells as a model for endocrine differentiation in
colorectal cancer. Virchows Arch B Cell Pathol Incl Mol Pathol.
62:311–320. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang X, Liu S, Zhang R, Sun B, Zhou S,
Chen R and Yu P: Microribonucleic acid-192 as a specific biomarker
for the early diagnosis of diabetic kidney disease. J Diabetes
Investigat. September 22–2017.(Epub ahead of print).
|
|
34
|
Li S, Jin Z and Lu X: MicroRNA-192
suppresses cell proliferation and induces apoptosis in human
rheumatoid arthritis fibroblast-like synoviocytes by downregulating
caveolin 1. Mol Cell Biochem. 432:123–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng S, Cong S, Zhang X, Bao X, Wang W, Li
H, Wang Z, Wang G, Xu J, Du B, et al: MicroRNA-192 targeting
retinoblastoma 1 inhibits cell proliferation and induces cell
apoptosis in lung cancer cells. Nucleic Acids Res. 39:6669–6678.
2011. View Article : Google Scholar : PubMed/NCBI
|
